Teva announced the launch of Tolterodine Tartrate Extended-Release Capsules, the generic version of Pfizer‘s Detrol LA Extended-Release Capsules.

RELATED: Urological Disorders Resource Center

Tolterodine is a muscarinic antagonist indicated for treatment of overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence. These agents lower intravesicular pressure, increase capacity, and reduce the frequency of bladder contractions. They block the parasympathetic nerves which control bladder voiding or exert a direct antispasmodic effect on the detrusor muscle.

Pfizer’s Tolterodine Tartrate Extended-Release Capsules are available in a 2mg and 4mg strength in 30-, 90-, and 500-count bottles.

For more information call (888) 838-2872 or visit